Authors
Latest:
Solutol HS15 as a Novel ExcipientThe authors present an update to the Wyeth/BASF experience with the IPEC Novel Excipient Safety Evaluation Procedure.
Latest:
Using Tocophersolan for Drug DeliveryTocophersolan or TPGS was developed 60 years ago as a water-soluble form of vitamin E. The author gives an overview of TPGS, including its interesting properties, examples found in the literature, and a brief summary of the regulatory status and marketed formulations.
Latest:
Mitigating Personnel RisksTraining cleanroom operators can be one of the most challenging aspects to maintaining cleanroom conditions. PTE speaks to Neal Wesley, technical director at SCM Pharma, to find out the best practices for training and ensuring continued compliance.
Latest:
Enhancing Dissolution of Poorly Soluble Drugs through Jet-MillingThe authors discuss a novel particle engineering technology based on mechano-chemical activation.
Latest:
In-Vivo Release Studies of Levamisole Phosphate and Ivermectin from an Isotropic Medium-Chain Mono and Diglyceride-Based Formulation Following Subcutaneous Injection in SheepFormulating an injectable solution containing both hydrophilic and hydrophobic drugs is a challenge.
Latest:
In-Vivo Release Studies of Levamisole Phosphate and Ivermectin from an Isotropic Medium-Chain Mono and Diglyceride-Based Formulation Following Subcutaneous Injection in SheepFormulating an injectable solution containing both hydrophilic and hydrophobic drugs is a challenge.
Latest:
In-Vivo Release Studies of Levamisole Phosphate and Ivermectin from an Isotropic Medium-Chain Mono and Diglyceride-Based Formulation Following Subcutaneous Injection in SheepFormulating an injectable solution containing both hydrophilic and hydrophobic drugs is a challenge.
Latest:
In-Vivo Release Studies of Levamisole Phosphate and Ivermectin from an Isotropic Medium-Chain Mono and Diglyceride-Based Formulation Following Subcutaneous Injection in SheepFormulating an injectable solution containing both hydrophilic and hydrophobic drugs is a challenge.
Latest:
Significant Changes in the 2014 IPEC Significant Change GuideA revision and modernization of the IPEC Significant Change Guide incorporates concepts of risk assessment.
Latest:
Considering Cold Chain NeedsMarket changes are driving pharmaceutical companies to consider new ways to mitigate risk in the cold chain.
Latest:
Considering Cold Chain NeedsMarket changes are driving pharmaceutical companies to consider new ways to mitigate risk in the cold chain.
Latest:
Novartis Announces EU Approval of Lung Cancer DrugNovartis announces that its lung cancer drug, Zykadia, gained European Union approval.
Latest:
Shifting Biopharma Strategies Shape Outsourcing MarketSmall- to medium-sized companies are expected to drive near-term growth of the global biomanufacturing outsourcing market.
Latest:
White paper: Effects of X-ray Inspection of Pharmaceutical ProductsThis paper answers a major concern of manufacturers: Do x-rays affect the quality and efficacy of a drug during product inspection?
Latest:
Managing Risk for Biomanufacturing Raw MaterialsUSP is developing new guidelines to help organizations prioritize risk and ensure raw material quality.
Latest:
USP Publishes Monoclonal Antibody GuidelinesA General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
Latest:
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesAssessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Latest:
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesAssessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Latest:
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesAssessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Latest:
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesAssessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Latest:
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesAssessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
